Grepafloxacin Articles
FDA says SB's Factive is non-approvable
18 December 2000
First approval for B-MS' Tequin heats up antibiotic sector - update
30 December 1999
First approval for B-MS' Tequin heats up antibiotic sector
24 December 1999
W-L withdraws clinafloxacin NDA
21 December 1999
SmithKline Beecham files for US approval of new quinolone
16 December 1999
Stock Commentary Europe
4 November 1999
GW withdraws Raxar on safety concerns
28 October 1999
GW files first dossiers for Flixotide in COPD
10 May 1999
Bayer Looking At Strong Growth, New Products
18 June 1998
1997: Another Good Year For New Chemical Entities
6 January 1998
FDA Clears Trovafloxacin With Ultra-Broad Indications
24 December 1997
GW's Grepafloxacin Launched In 2nd Market, The USA
24 December 1997
Grepafloxacin Cleared For Marketing In USA
11 November 1997
Will New Wave Of Antibiotics Fight Resistance?
23 October 1997
First Approval For Glaxo Wellcome's Grepafloxacin
4 August 1997
Glaxo Wellcome's Promising New Antibiotic
10 July 1997
Glaxo Wellcome's Promising New Antibiotic
8 July 1997
New Data With Glaxo Wellcome's Raxar
9 June 1997
Investors Impressed With Glaxo Wellcome Pipeline
12 May 1997
Glaxo Wellcome 1996 Product Performance
17 March 1997
Glaxo Wellcome Licences Otsuka's Grepafloeacin
10 June 1996
Showing 1-27 of 27 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
